In Response to Increasing Cases, Hadassah AIDS Center Gets Proactive
The Hadassah AIDS Center will conduct an in-service seminar on AIDS awareness and prevention for family doctors this coming Wednesday, October 2. The seminar, "HIV-A Virus Without Borders", is being organized as a result of the recent increase in AIDS cases among residents of East Jerusalem. Nearly half of the cases weren’t diagnosed until the advanced stages of the virus even though patients felt sick and were seen by doctors.
The AIDS Center at Hadassah was established in 1985 and the multidisciplinary team provides diagnosis, treatment and support for HIV/AIDS patients. Additionally, the center conducts various studies on HIV/AIDS. The center is currently treating around 400 HIV carriers: Jews, Arabs and Christians.
The Institute of General Medicine comprises thirteen departments and nine Centers of Excellence. Each a leader in its field, the Centers include the Unit for the Early Detection of Colorectal Cancer, Center for Aging Research, National Center for Down Syndrome, and National SLE (LUPUS) Center. Its stellar Intensive Care Unit is world renowned.
"This virus doesn’t only affect what would be considered 'classic' high-risk groups where physicians might be looking for symptoms,” said AIDS Center Director Dr. Hila Elinav. “Family physicians don’t think of HIV when examining the men, women and children from their regular practices, and they are missing the initial signs. There is less openness about homosexuality and drug use. That means that patients are diagnosed dangerously late, and arrive at the Center much later than they should and have a lower chance of overcoming the virus. Early detection of the disease, while it is still in the carrier stage can help slow the virus and prevent the development of AIDS."
The seminar will include lectures on diagnosis methods, early symptoms, treatment options, quality of life and life-expectancy. The seminar will take place at the Dan Hotel in Jerusalem.
Hadasit, Hadassah’s Technology Transfer Arm, Reviews
When the Hadassah University Medical Center’s physicians suggest a
solution to a medical problem which can lead to the development of a new
medicine or product, Hadasit, Hadassah’s technology transfer arm, explores its
feasibility and supports the promotion of those viable ideas with innovation
potential. Although 2012 has been “a year full of challenges for the life
science industry,” says Einat Zisman, Hadasit’s Chief Executive Officer,
Hadasit still signed 125 agreements for clinical trials, all to be done at
Hadassah. In addition, Hadasit signed 15 agreements for cooperation and
commercialization of technologies that were developed at Hadassah. Click here
to read the latest Newsletter from Hadasit >>